Empagliflozin Eyed for Outpatient Chronic Hyponatremia - Medscape
6/21/2022 12:00:00 AM3 years 8 months ago
by Miriam E. Tucker
by Miriam E. Tucker
The SGLT2 inhibitor increased sodium and reduced neurocognitive dysfunction in patients with chronic hyponatremia due to the syndrome of inappropriate antidiuresis.
Empagliflozin is a potential treatment for outpatients with chronic hyponatremia due to the syndrome of inappropriate antidiuresis (SIAD), new data suggest. The sodium-glucose cotransporter 2 (SGLT… [+6535 chars]
full article...